Moderna shares up after FDA pauses J&J vaccine on blood clot concerns
Moderna shares up after FDA pauses J&J vaccine on blood clot concerns

Yahoo Finance’s Myles Udland and Brian Sozzi spoke with Hartaj Singh, Oppenheimer Analyst about Moderna, Johnson & Johnson, and the biotech space.